InvestLog
LENZ logo

LENZ

LENZ Therapeutics, Inc.NASDAQHealthcare
$9.67+3.42%ClosedMarket Cap: $303.2M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-26Citigroup—Buy—
2026-03-25B of A Securities—Buy—
2025-10-20Raymond James—Outperform—
2025-10-10Piper Sandler—Overweight—
2025-08-01Citigroup—Buy—
2025-08-01HC Wainwright & Co.—Buy—
2025-07-31Raymond James—Outperform—
2025-05-08HC Wainwright & Co.—Buy—
2025-04-14Piper Sandler—Overweight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-2.94$49.5M6
Fri Dec 31$-2.55$84.5M5
Sun Dec 31$-0.50$165.8M4
Mon Dec 31$1.96$280.9M2